http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae0bd795b8ebc7d03919391db4af7eca
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Galimi |
| name | Francesco Galimi |
| given-name | Francesco |
| organization-name | Authors' Affiliations: Laboratories of 1Molecular Pharmacology, 2Functional Genomics, 3Systems Biology, and 4Cancer Genetics, 5Division of Surgical Oncology, 6Unit of Pathology, Institute for Cancer Research and Treatment (IRCC), Candiolo; 7Department of Surgery, 8Unit of Pathology, Mauriziano Umberto I Hospital; 9Liver Transplantation Center, 10Department of Pathology, San Giovanni Battista Hospital, Torino, Italy; 11Ortho Biotech Oncology Research and Development, Beerse, Belgium; and 12Department of Oncological Sciences, University of Torino Medical School, Candiolo, Torino, Italy *Department of Biomedical Sciences, University of Sassari Medical School, Sassari, Italy and From the Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA; and the Department of Biomedical Sciences/Instituto Nazionale di Biostrutture e Biosistemi, University of Sassari Medical School, Sassari, Italy. Amgen Inc. South San Francisco California 2Department of Oncology, University of Torino Medical School, Torino, Italy.; 3Translational Cancer Medicine, Candiolo Cancer Institute – FPO IRCCS, Torino, Italy. Authors' Affiliations: 1Division of Molecular Oncology and 2Laboratory of Functional Genomics, The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, Candiolo, Turin, Italy and 3Cancer and Infection Research Area, AstraZeneca, Macclesfield, Cheshire, United Kingdom Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, CA 92037;; Department of Biomedical Sciences/Istituto Nazionale di Biostrutture e Biosistemi, University of Sassari Medical School, 07100 Sassari, Italy; and University of Sassari Medical School/INBB, Italy.; The Salk Institute, San Diego, CA, USA. Department of Biomedical Sciences / INBB, University of Sassari Medical School, Viale San Pietro 43/C, 07100 Sassari (SS), Italy Authors' Affiliations: 1Department of Oncology, University of Torino; 2IRCC Institute for Cancer Research and Treatment at Candiolo, Candiolo, Torino; 3FIRC Institute of Molecular Oncology (IFOM); 4Division of Pathology and 5Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy;6Janssen Research and Development, Beerse, Belgium; and 7Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland; Authors' Affiliations: 1Department of Oncology, University of Torino; 2IRCC Institute for Cancer Research and Treatment at Candiolo, Candiolo, Torino; 3FIRC Institute of Molecular Oncology (IFOM); 4Division of Pathology and 5Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy;6Janssen Research and Development, Beerse, Belgium; and 7Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Molecular Genetics, 3Division of Surgical Oncology, 4Unit of Pathology, 5Clinical Coordination Unit, 6Molecular Clinical Oncology, Institute for Cancer Research and Treatment (IRCC); 7Department of Oncological Sciences, University of Torino Medical School, Candiolo; 8Department of Surgery, Mauriziano Umberto I Hospital, Torino; 9Southern Europe New Drug Organization (SENDO) Foundation; and 10FIRC Institute of Molecular Oncology (IFOM), Milano, Italy Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Torino Medical School, 10060 Candiolo (Torino), Italy. Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037 From the Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA; and the Department of Molecular and Medical Genetics, Oregon Health Science University, Portland. Giorgio V. Scagliotti, University of Turin, S. Luigi Hospital, Turin, Italy; Ihor Vynnychenko, Sumy State University, Sumy; Oleksandr Sydorenko, Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine; Keunchil Park, Sungkyunkwan University School of Medicine, Seoul, Korea; Yukito Ichinose, National Kyushu Cancer Center, Fukuoka; Kaoru Kubota, Nippon Medical School, Tokyo, Japan; Fiona Blackhall, The Christie National Health Services Foundation Trust, Manchester, United Kingdom; Robert Pirker,... Department of Oncology, University of Torino Medical School, 10060 Candiolo, Torino, Italy.; Translational Cancer Medicine, Candiolo Cancer Institute–Fondazione del Piemonte per l’Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 10060 Candiolo, Torino, Italy. Department of Biomedical Sciences and National Institute of Biostructures and Biosystems, University of Sassari, VIale S.Pietro 43/C, I-07100 Sassari, Italy. Department of Biomedical Sciences/INBB, University of Sassari, Sassari, Italy Department of Biomedical Sciences/Instituto Nazionale di Biostrutture e Biosistemi, University of Sassari Medical School, 07100 Sassari, Italy; and Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Oncogenomics, 3Laboratory of Systems Biology, 4Laboratory of Molecular Genetics, 5Division of Surgical Oncology, 6Unit of Pathology, 7Clinical Coordination Unit, and 8Molecular Clinical Oncology, Institute for Cancer Research and Treatment, Torino; Departments of 9Oncological Sciences and 10Biomedical Sciences and Human Oncology, University of Torino Medical School, Torino; 11Department of Surgery, Mauriziano Umberto I Hospital, Torino; 12FIRC Institute of Molecular Oncology, Milano; 13Division of Pathology, 14Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano; and 15Southern Europe New Drug Organization Foundation, Milano, Italy The Salk Institute for Biological Studies, La Jolla, California |
Incoming Links
Total number of triples: 73.